Anna M. Dahlin
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Peptidase Inhibition and Analysis
- Cancer Research top 10%
Papers in
-
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 3
- Genetics 5
- Glioma Diagnosis and Treatment 5
- Co-authors
- Richard Palmqvist (10 shared papers)Åke Öberg (8 shared papers)Martin Rutegård (7 shared papers)Sofia Edin (5 shared papers)Maria L. Wikberg (3 shared papers)Bethany R. Van Guelpen (7 shared papers)Maria L. Henriksson (6 shared papers)Per‐Arne Oldenborg (2 shared papers)
- Journals
- PLoS ONE (5 papers)Journal of Neuro-Oncology (4 papers)International Journal of Cancer (3 papers)Cancer Causes & Control (3 papers)European Journal of Clinical Pharmacology (2 papers)
- Partner nations
- SwedenUnited StatesDenmark
In The Last Decade
Anna M. Dahlin
35 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 102
- Oncology 768
- Cancer Research 304
- Immunology 347
- Pulmonary and Respiratory Medicine 471
- Pathology and Forensic Medicine 232
Countries citing papers authored by Anna M. Dahlin
This map shows the geographic impact of Anna M. Dahlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Dahlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Dahlin more than expected).
Fields of papers citing papers by Anna M. Dahlin
This network shows the impact of papers produced by Anna M. Dahlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Dahlin. The network helps show where Anna M. Dahlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna M. Dahlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 407 | |
| 2 | 2013 | 213 | |
| 3 | 2011 | 199 | |
| 4 | 2010 | 178 | |
| 5 | 2013 | 151 | |
| 6 | 2010 | 150 | |
| 7 | 2013 | 149 | |
| 8 | 2011 | 119 | |
| 9 | 2011 | 62 | |
| 10 | 2011 | 37 | |
| 11 | 2009 | 36 | |
| 12 | 2007 | 35 | |
| 13 | 2016 | 29 | |
| 14 | 2017 | 26 | |
| 15 | 2012 | 23 | |
| 16 | 2015 | 17 | |
| 17 | 2015 | 15 | |
| 18 | 2019 | 13 | |
| 19 | 2019 | 12 | |
| 20 | 2019 | 11 |
About Anna M. Dahlin
Anna M. Dahlin is a scholar working on Cancer Research, Genetics, Oncology, Molecular Biology and Pharmacology, having authored 35 papers that have together received 2.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (5 papers), Epigenetics and DNA Methylation (5 papers), Cancer-related molecular mechanisms research (3 papers), MicroRNA in disease regulation (3 papers), Ferroptosis and cancer prognosis (2 papers), Pharmacology and Obesity Treatment (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers) and Hedgehog Signaling Pathway Studies (2 papers). The work is most often cited by research in Oncology (768 citations), Cancer Research (304 citations), Immunology (347 citations), Pulmonary and Respiratory Medicine (471 citations) and Pathology and Forensic Medicine (232 citations). Anna M. Dahlin has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Richard Palmqvist, Åke Öberg, Martin Rutegård, Sofia Edin, Maria L. Wikberg, Bethany R. Van Guelpen, Maria L. Henriksson, Per‐Arne Oldenborg, Roger Stenling and Vincy Eklöf. Their work appears in journals such as PLoS ONE, Journal of Neuro-Oncology, International Journal of Cancer, Cancer Causes & Control and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.